Heart attack inflammation: small study maps CRP changes after emergency procedure

NCT ID NCT05233176

Completed Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at how levels of C-reactive protein (CRP), a marker of inflammation, change in 35 patients having emergency angioplasty for a heart attack. Researchers took blood samples before the procedure and at several time points up to 30 days after. The goal was to better understand the body's inflammatory response during recovery, which may help improve future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better understand inflammation after a heart attack and guide future treatment timing.
What could go wrong: This is a small, observational study with only 35 participants. It does not test a treatment, so it cannot directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROME

Contacts and locations

Locations

Cardiology department, Ambroise Paré hospital, APHP

Boulogne-Billancourt, 92100, France
Intensive care unit, Ambroise Paré hospital, APHP

Boulogne-Billancourt, 92100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.